Search bioRxiv⌕ Search

Biology subjects

Gartner, C.

Publications and source records attributed to Gartner, C..

2 recordsLinked to original sources

Deletion of Dock7 Exons 3 and 4 Results in Reduced Trabecular Microarchitecture and a Decrease in Mineralization

Dedicator of Cytokinesis 7 (DOCK7) has recently emerged as a regulator of skeletal homeostasis, but existing Dock7 mutant models harbor only global mutations and are incompatible with tissue-specific deletion studies. We previously generated a Dock7-floxed allele in which exons 3-4 are flanked by LoxP sites. To validate the utility of this allele for future conditional strategies, we globally deleted exons 3-4 to generate Dock7em2/em2 mice and characterized their skeletal phenotype. Homozygous Dock7em2/em2 mice exhibited a diluted coat color and white belly spot, consistent with spontaneous Dock7 mutations, whereas heterozygotes exhibited no spotting or coat changes. Bone microarchitecture was assessed in 21-week-old males and females. Global deletion of Dock7 exons 3-4 resulted in a 30-37% reduction in trabecular bone volume in the distal femur and L5 vertebrae. Cortical bone thickness was unchanged, though sex-specific alterations in femoral area suggested altered appositional bone growth. Mass spectrometry (SWATH) analysis of Dock7em2/em2 bone marrow stromal cells (BMSCs) identified DOCK7 protein levels similar to control mice, likely resulting from an alternative translational start site. Despite stable protein abundance prior to differentiation, BMSCs from Dock7em2/em2 mice exhibited reduced mineralization and decreased Bglap expression, indicating attenuated osteoblast differentiation. These findings demonstrate that Dock7 exons 3-4 are required for normal trabecular bone acquisition and osteoblast function. While the Dock7-em2 allele likely encodes a truncated protein product, its recapitulation of the Misty skeletal phenotype confirms that exons 3-4 are essential for DOCK7 activity. These studies in the Dock7em2/em2 mouse provide a foundation for future tissue-specific deletion studies utilizing the Dock7 exon 3-4 deletion model to define the cellular roles of DOCK7 in regulating bone formation and trabecular architecture. Lay SummaryIdentifying genes that regulate bone mass is essential for understanding osteoporosis. Mutation of the Dock7 gene in mice results in low bone mass, similar to human osteoporosis. Previous models could not isolate its role in specific tissues, limiting our ability to understand how DOCK7 controls bone mass. We developed a new mouse model where Dock7 can be mutated in specific tissues. In this study, we bred mice to carry this mutation across all tissues, causing significant bone loss. This validates a flexible tool for future research to mutate DOCK7 in specific cell types and map its role in skeletal health.

cell biology↗

Lipidomic and Proteomic Insights from Extracellular Vesicles in Postmortem Dorsolateral Prefrontal Cortex Reveal Substance Use Disorder-Induced Brain Changes

Substance use disorder (SUD) significantly increases the risk of neurotoxicity, inflammation, oxidative stress, and impaired neuroplasticity. The activation of inflammatory pathways by substances may lead to glial activation and chronic neuroinflammation, potentially mediated by the release of extracellular particles (EPs), such as extracellular condensates (ECs) and extracellular vesicles (EVs). These particles, which reflect the physiological, pathophysiological, and metabolic states of their cells of origin, might carry molecular signatures indicative of SUD. In particular, our study investigated neuroinflammatory signatures in SUD by isolating EVs from the dorsolateral prefrontal cortex (dlPFC) Brodmanns area 9 (BA9) in postmortem subjects. We isolated BA9-derived EVs from postmortem brain tissues of eight individuals (controls: n=4, SUD: n=4). The EVs were analyzed for physical properties (concentration, size, zeta potential, morphology) and subjected to integrative multi-omics analysis to profile the lipidomic and proteomic characteristics. We assessed the interactions and bioactivity of EVs by evaluating their uptake by glial cells. We further assessed the effects of EVs on complement mRNA expression in glial cells as well as their effects on microglial migration. No significant differences in EV concentration, size, zeta potential, or surface markers were observed between SUD and control groups. However, lipidomic analysis revealed significant enrichment of glycerophosphoinositol bisphosphate (PIP2) in SUD EVs. Proteomic analysis indicates downregulation of SERPINB12, ACYP2, CAMK1D, DSC1, and FLNB, and upregulation of C4A, C3, and ALB in SUD EVs. Gene ontology and protein-protein interactome analyses highlight functions such as cell motility, focal adhesion, and acute phase response signaling that is associated with the identified proteins. Both control and SUD EVs increased C3 and C4 mRNA expression in microglia, but only SUD EVs upregulated these genes in astrocytes. SUD EVs also significantly enhanced microglial migration in a wound healing assay.This study successfully isolated EVs from postmortem brains and used a multi-omics approach to identify EV-associated lipids and proteins in SUD. Elevated C3 and C4 in SUD EVs and the distinct effects of EVs on glial cells suggest a crucial role in acute phase response signaling and neuroinflammation.

neuroscience↗